Preclinical News and Research

RSS
Takeda, Heptares collaborate to develop new drugs against CNS disorders

Takeda, Heptares collaborate to develop new drugs against CNS disorders

Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment

Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment

Polaris' ADI-PEG 20 exhibits potential against AML, GBM and bladder cancer

Polaris' ADI-PEG 20 exhibits potential against AML, GBM and bladder cancer

New publication on therapeutic hypothermia and temperature management

New publication on therapeutic hypothermia and temperature management

BioParadox's VitaKine PCT can serve as promising therapy for heart attack patients

BioParadox's VitaKine PCT can serve as promising therapy for heart attack patients

Powerful natural formula is an effective treatment for men with prostate cancer

Powerful natural formula is an effective treatment for men with prostate cancer

OncoGenex, Teva's custirsen preclinical data in CRPC presented at AACR meeting

OncoGenex, Teva's custirsen preclinical data in CRPC presented at AACR meeting

NIH awards HemoShear with Phase I SBIR grant to develop rodent liver system

NIH awards HemoShear with Phase I SBIR grant to develop rodent liver system

Circadian's VGX-100 neutralises VEGF-C and inhibits tumour growth in mouse models of human cancers

Circadian's VGX-100 neutralises VEGF-C and inhibits tumour growth in mouse models of human cancers

VBL's VB-111 preclinical data against metastatic cancer presented at AACR meeting

VBL's VB-111 preclinical data against metastatic cancer presented at AACR meeting

BioWa, OBT enter license agreement to advance ADCC programs

BioWa, OBT enter license agreement to advance ADCC programs

Celldex presents CDX-1127 preclinical data against cancer at AACR meeting

Celldex presents CDX-1127 preclinical data against cancer at AACR meeting

Avila's PI3Kα inhibitor preclinical study data presented at AACR meeting

Avila's PI3Kα inhibitor preclinical study data presented at AACR meeting

Pervasis' PVS-30200 study data in prostate cancer presented at AACR meeting

Pervasis' PVS-30200 study data in prostate cancer presented at AACR meeting

NIAID awards Aragen Bioscience with three subcontracts to advance preclinical studies

NIAID awards Aragen Bioscience with three subcontracts to advance preclinical studies

ARIAD's ponatinib potently inhibits all four FGFRs abnormally expressed in multiple cancers

ARIAD's ponatinib potently inhibits all four FGFRs abnormally expressed in multiple cancers

La Jolla acquires GliaMed's novel class of compounds

La Jolla acquires GliaMed's novel class of compounds

Aeterna Zentaris presents two posters on perifosine at AACR meeting

Aeterna Zentaris presents two posters on perifosine at AACR meeting

OncoGenex presents OGX-427 preclinical data in prostrate cancer at AACR meeting

OncoGenex presents OGX-427 preclinical data in prostrate cancer at AACR meeting

Synta presents ganetespib and elesclomol study data in cancer at AACR meeting

Synta presents ganetespib and elesclomol study data in cancer at AACR meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.